Citation: | FU Huayu, SU Jiasun, HUANG Jing, XU Juanjuan, LI Meng, HUANG Jinai, DU Juan, LI Jiao. The necessity study of prenatal diagnosis in fetal nuchal translucency from 2.5 to 2.9 mm[J]. Chinese Journal of General Practice, 2025, 23(6): 972-976. doi: 10.16766/j.cnki.issn.1674-4152.004045 |
[1] |
赵欣荣, 王彦林, 范阳阳, 等. 胎儿颈项透明层增厚的临床咨询及预后分析[J]. 上海交通大学学报(医学版), 2018, 38(5): 529-532.
ZHAO X R, WANG Y L, FAN Y Y, et al. Clinical consultation and prognosis analysis of fetus with increased nuchal translucency[J]. J Shanghai Jiaotong University(medical science), 2018, 38(5): 529-532.
|
[2] |
倪梦瑶, 李洁, 朱湘玉, 等. 染色体微阵列分析在颈项透明层增厚胎儿产前诊断中的应用[J]. 中华医学遗传学杂志, 2019, 36(10): 970-974.
NI M Y, LI J, ZHU X Y, et al. Application of chromosomal microarray analysis in prenatal diagnosis of fetuses with increased nuchal translucency[J]. Chin J Med Genet, 2019, 36(10): 970-974.
|
[3] |
American College of Obstetricians and Gynecologists (ACOG). Screening for fetal chromosomal abnormalities. ACOG practice bullet in No. 226[J]. Obstet and Gynecol, 2020, 136(4): e48-e69.
|
[4] |
ARMOUR C M, DOUDAN S D, BROCK J A, et al. Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada[J]. J Med Genet, 2018, 55(4): 215-221.
|
[5] |
LEUNG T Y, AU YEUNG K C, LEUNG W C, et al. Prenatal diagnosis of pathogenic genomic imbalance in fetuses with increased nuchal translucency but normal karyotyping using chromosomal microarray[J]. Hong Kong Med J, 2019, 25(4): 30-32.
|
[6] |
BOUTOTA M, YARDIN C, MARTIN R, et al. Follow-up of increased nuchal translucency: results of a study of 398 cases[J]. J Gynecol Obstet Hum Reprod, 2022, 51(10): 102482. DOI: 10.1016/j.jogoh.2022.102482.
|
[7] |
BUNNELL M E, ADAMS S, PELLETIER A, et al. Increased use of diagnostic testing after increased nuchal translucency: the influence of non-invasive prenatal testing and chromosomal microarray[J]. Prenat Diagn, 2022, 42(13): 1606-1611.
|
[8] |
黄婷婷, 周萍, 黎俏, 等. 颈项透明层增厚在产前诊断中的应用[J]. 实用医学杂志, 2020, 36(15): 2152-2156.
HUANG T T, ZHOU P, LI Q, et al. Application research of fetus with increased nuchal translucency in prenatal diagnosis[J]. Journal of Practical Medicine, 2020, 36(15): 2152-2156.
|
[9] |
SU L J, HUANG H L, AN G, et al. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype[J]. Mol Genet Genomic Med, 2019, 7(8): e811. DOI: 10.1002/mgg3.811.
|
[10] |
李萌, 蒙达华, 付华钰, 等. 199例妊娠中晚期胎儿室间隔缺损的遗传学因素研究[J]. 中华全科医学, 2023, 21(2): 267-269. doi: 10.16766/j.cnki.issn.1674-4152.002861
LI M, MENG D H, FU H Y, et al. Genetic factors of ventricular septal defect in 199 cases in the second or third trimester of pregnancy[J]. Chin J General Practice, 2023, 21(2): 267-269. doi: 10.16766/j.cnki.issn.1674-4152.002861
|
[11] |
SUN Y Y, LIU L, ZHI Y X, et al. Genetic examination for fetuses with increased nuchal translucency by exome sequencing[J]. J Obstet Gynaecol Res, 2023, 49(2): 530-538.
|
[12] |
卢虞夫, 赵靖, 雷榆, 等. 无创DNA产前检测对胎儿染色体非整倍体疾病筛查的临床意义[J]. 贵州医科大学学报, 2022, 47(5): 598-603.
LU Y F, ZHAO J, LEI Y, et al. Clinical significance of non-invasive DNA prenatal detection for fetal chromosomal aneuploidy disease screening[J]. Journal of Guizhou Medical University, 2022, 47(5): 598-603.
|
[13] |
NARAVA S, SINGH S B, BARPANDA S, et al. Outcome of pregnancies with first-trimester increased nuchal translucency and cystic hygroma in a tertiary maternity hospital in United Arab Emirates[J]. Int J Gynaecol Obstet, 2022, 159(3): 841-849.
|
[14] |
TEKESIN I. Pregnancy outcome in foetuses with increased nuchal translucency-10-years'experience in a prenatal medical practice[J]. J Obstet Gynaecol, 2020, 40(4): 455-460.
|
[15] |
SOFIA-GONÇALVES A, GUEDES-MARTINS L. Nuchal translucency and congenital heart defects[J]. Curr Cardiol Rev, 2024, 20(2): 1-13.
|
[16] |
HURYN L A, FLAHERTY T, NOLEN R, et al. Novel ophthalmic findings and deep phenotyping in Williams-Beuren syndrome[J]. Br J Ophthalmol, 2023, 107(10): 1554-1559.
|
[17] |
ALQAHTANI A S, PUTOUX A, BONNET DUPEYRON M N, et al. Postnatal clinical phenotype of five patients with Pallister-Killian syndrome (tetrasomy 12p): interest of array CGH for diagnosis and review of the literature[J]. Mol Genet Genomic Med, 2019, 7(10): e00939. DOI: 10.1002/mgg3.939.
|
[18] |
中华医学会医学遗传学分会遗传病临床实践指南撰写组. Rett综合征的临床实践指南[J]. 中华医学遗传学, 2020, 37(3): 308-312.
Writing Group for Practice Guidelines for Diagnosis and Treatment of Genetic Diseases, Medical Genetics Branch of Chinese Medical Association. Clinical practice guidelines for Rett syndrome[J]. Chin J Med Genet, 2020, 37(3): 308-312.
|
[19] |
SU J S, QIN Z L, FU H Y, et al. The correlations of prenatal renal ultrasound abnormalities with pathogenic CNVs in a large Chinese cohort[J]. Ultrasound Obstet Gynecol, 2022, 59(2): 226-233.
|
[20] |
BETA J, ZHANG W, GERIS S, et al. Procedure-related risk of miscarriage following chorionic villus sampling and amniocentesis[J]. Ultrasound Obstet Gynecol, 2019, 54(4): 452-457.
|
[21] |
于艳, 杨彦. 羊水穿刺与无创DNA产前检测的对照研究[J]. 现代医药卫生, 2021, 37(5): 803-806.
YU Y, YANG Y. Comparative study of amniocentesis and non-invasive prenatal testing[J]. J Mod Med Health, 2021, 37(5): 803-806.
|